We are a Norwegian pharmaceutical company. As a dedicated European producer of high quality Metformin, we are well positioned to supply the growing global market.
Vistin Pharma today produce about 10% of the world’s demand for Metformin HCl API and have in 2022 initiated a project to double the manufacturing capacity. Our Metformin is also available as direct compressible lubricated granules. Vistin Pharma Headquarter is located in Oslo, Norway. Our manufacturing facility is located in Kragerø, Norway. The facility is certified according to current Good Manufacturing Practice (cGMP) and successfully inspected by the US Food and Drug Administration (FDA).
Vistin Pharma AS was established in June 2015, when Vistin Pharma AS acquired the B2B business of Weifa AS.
2015
Served areaWorldwide
HeadquartersPostboks 6735 Etterstad, 0609 Oslo – Norway
44,344,592
IPOOct. 3, 2018
Stock exchange(s)Euronext Oslo